I S Misko - Concepedia

Author

I S Misko

QIMR Berghofer Medical Research Institute

Also Known As

I MISKO, I Misko, I S MISKO, I S Misko, I. Misko, I. S. MISKO, I. S. Misko, I.S. Misko, IHOR S MISKO, IHOR S. MISKO

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

QIMR Berghofer Medical Research Institute The University of Queensland Australian National University Australian Red Cross Lifeblood

About

I S Misko is an author at QIMR Berghofer Medical Research Institute specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	2.3K
2	Cell Biology	13	13	817
3	Allergy	3	3	167
4	Cellular Physiology	1	1	36
5	Cellular Therapies	1	1	109

I S Misko

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. Rajiv Khanna, Scott R. Burrows, Michael G. Kurilla, The Journal of Experimental Medicine VaccinationTarget EpitopesUbiquitous Epstein-barr VirusVaccine DevelopmentVaccine Research	1992	390
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. Victor Argaet, Christopher Schmidt, Scott R. Burrows, The Journal of Experimental Medicine Persistent InfectionSystems BiologyEpstein-barr VirusNeurovirologyMemory Response	1994	277
Long-term T-cell-mediated immunity to Epstein-Barr virus. Alan B. Rickinson, Denis J. Moss, Lesley E. Wallace, PubMed Epstein-barr VirusAdaptive Immune SystemImmunologyT Cell ImmunityMedicine	1981	211
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants Denis J. Moss, I S Misko, Scott R. Burrows, Nature Adaptive Immune SystemImmunologyPathologyVirologyAutoimmunity	1988	191
T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. Scott R. Burrows, Sharon L. Silins, Denis J. Moss, The Journal of Experimental Medicine Autoimmune DiseaseEbv EpitopePublic TcrAdaptive Immune SystemT-regulatory Cell	1995	185
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). Scott R. Burrows, T B Sculley, I S Misko, The Journal of Experimental Medicine Epstein-barr VirusMedicineImmunologyAntiviral ResponsePathology	1990	172
Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load Sharon L. Silins, Martina A. Sherritt, Jodie M. Silleri, Blood	2001	118
Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen Kevin J. Lafferty, I S Misko, Margaret A. Cooley Nature Transplant RejectionCell TherapyTransplantationAutoimmune DiseaseT Cells	1974	109
A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy K.A.O. Ellem, Michael G. E. OʼRourke, Gregory R. Johnson, Cancer Immunology Immunotherapy Clinical CourseFirst Human UseGranulocyteImmunoengineeringImmunology	1997	101
HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. I S Misko, Dennis Moss, J. H. Pope Proceedings of the National Academy of Sciences HistocompatibilityPreferred SpecificityAllergyRelease AssayEpstein-barr Virus	1980	100

Page 1